Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...
Zacks Small Cap Research on MSN2h
RVPH: Year-End OLE UpdateRVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...
Q3 2024 Earnings Call Transcript November 18, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx ...
Two papers published in Journal of Orthopaedic Research Spine show the promise of PP353 through preclinical development and ...
TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product, TAH3311, an innovative antithrombotic oral dissolving film (ODF). In ...
Dermatologists and experts advise consumers to carefully check labels and be wary of many products on the market, especially those on social media, that may contain harmful substances.
Weight-loss drugs promise to make the pounds melt away, and beauty products and fillers will erase those fine lines. But do you know what you're getting or where it's coming from?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback